Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer
- 18 May 2006
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 236 (2) , 269-275
- https://doi.org/10.1016/j.canlet.2005.05.015
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Time trends in cancer mortality in China: 1987–1999International Journal of Cancer, 2003
- Inflammation and cancerNature, 2002
- Genetic polymorphisms and lung cancer susceptibility: a reviewLung Cancer, 2002
- The balance between IL-1 and IL-1Ra in diseaseCytokine & Growth Factor Reviews, 2002
- Influence of Interleukin‐1 Receptor Antagonist Gene Polymorphism on DiseaseClinical Infectious Diseases, 2002
- Proinflammatory Cytokine Levels in Patients with Lung Cancer and Carcinomatous PleurisyRespiration, 1998
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's diseaseThe Lancet, 1992
- Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancerGynecologic Oncology, 1991